The Trump administration has shown that it’s willing to buy up stakes in publicly traded companies, a level of intervention that some say is unprecedented.
Related Posts
Bristol Myers Squibb tops quarterly estimates, hikes outlook as drugmaker braces for tariffs
The guidance revisions include the estimated impact of current tariffs on U.S. products shipped to China, but not Trump’s planned pharmaceutical tariffs.
Dell forecasts $15 billion of AI server sales this year
Dell said that it sold about $10 billion of AI-optimized servers in its fiscal 2025, and expects to sell about $15 billion in AI system […]
Dow futures are little changed after index drops 1,100 points in 10th straight loss: Live updates
Wall Street was previously betting on the Fed keeping an aggressive rate-cutting stance through 2025, hoping to extend the bull market.